This inventor holds 7 USPTO granted patents and 1 published patent application and 5 EPO patents. Top assignees: Padlock Therapeutics, Inc., Ucb Biopharma Sprl, Novartis Ag. Active years: 2014-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Oxon, GB (2014)
- Abingdon, GB (2016 - 2024)
Company Filing History:
4 out of 6 
2 out of 139 
1 out of 3,978 
Years Active: 2014-2024
Title: Laura Gleave: Pioneering Innovator in PAD4 Inhibitor Development
Introduction
Laura Gleave is an accomplished inventor based in Abingdon, Great Britain, with a notable portfolio of six patents. Her work primarily focuses on innovative compounds that serve as inhibitors of PAD4, which play a crucial role in treating various PAD4-related disorders.
Latest Patents
Among her latest patents, Gleave's inventions, titled "Heteroaryl inhibitors of PAD4," detail compounds that demonstrate efficacy in inhibiting PAD4. The patents cover not only the compounds themselves but also compositions that can be derived from them, along with methodologies for treating disorders associated with PAD4. This groundbreaking work holds significant promise for advancing treatment options in the medical field.
Career Highlights
Laura Gleave has built a distinguished career at prominent organizations focused on biopharmaceutical advancements. She has worked at Padlock Therapeutics, Inc. and UCB Biopharma S.A., contributing her expertise in medicinal chemistry and pharmacology. Her dedication to innovative research has led to substantial developments in the understanding and application of PAD4 inhibitors.
Collaborations
In her journey as an inventor, Gleave has collaborated with talented professionals in her field. Notable colleagues include Rajesh Devraj and Gnanasambandam Kumaravel, who have contributed to the development and refinement of her innovative compounds. These collaborations highlight the importance of teamwork and shared expertise in driving forward advancements in science and medicine.
Conclusion
Laura Gleave's contributions through her patented inventions are paving the way for new therapeutic strategies targeting PAD4-related disorders. With her innovative spirit and collaborative efforts, she continues to make significant strides in the field of biopharmaceuticals, showcasing the transformative power of dedicated inventors in advancing healthcare technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile